$AMBS Amarantus Completes Enrollment of 72 Patient LP-002 Clinical Study

“We look forward to releasing additional univariate data from the originally-planned 72 patient LP-002 clinical study in the near-term,” said Gerald E. Commissiong, President & CEO of Amarantus. “We believe this data set will further position Amarantus to successfully target our initial Research Use Only (RUO) customer with LymPro as a stage-independent diagnostic, as discussed in our recent business update call.”

http://ir.stockpr.com/amarantus/company-news/detail/1634/amarantus-completes-enrollment-of-72-patient-lp-002-clinical-study-for-alzheimers-blood-diagnostic-lympro-testr

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s